Treating the SARS-CoV-2-positive patient with cancer: A proposal for a pragmatic and transparent ethical process.
Cancer
; 126(17): 3896-3899, 2020 09 01.
Article
en En
| MEDLINE
| ID: mdl-32463478
ABSTRACT
The treatment of patients with cancer who test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses unique challenges. In this commentary, the authors describe the ethical rationale and implementation details for the creation of a novel, multidisciplinary treatment prioritization committee, including physicians, frontline staff, an ethicist, and an infectious disease expert. Organizational obligations to health care workers also are discussed. The treatment prioritization committee sets a threshold of acceptable harm to patients from decreased cancer control that is justified to reduce risk to staff. The creation of an ethical, consistent, and transparent decision-making process involving such frontline stakeholders is essential as departments across the country are faced with decisions regarding the treatment of SARS-CoV-2-positive patients with cancer.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Calidad de la Atención de Salud
/
Personal de Salud
/
Infecciones por Coronavirus
/
Atención a la Salud
/
Pandemias
/
Betacoronavirus
/
Neoplasias
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
En
Año:
2020
Tipo del documento:
Article